Amyloid precursor protein (APP) is a type 1 transmembrane glycoprotein that is widely recognized for its involvement in the pathogenesis and progression of Alzheimer’s disease (AD), and neuronal homeostasis [7,8,9]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.